News
THE Georgetown Public Hospital Corporation (GPHC) has been promoting vision care through early screenings and tests at its eye clinic and the Vision Centre.
As we grow older, so does our body, and after 45, many health issues catch up. However, these signals develop gradually, so ...
Analysis - Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world.
The researchers focused on a protein called hypoxia-inducible factor (HIF), which has been linked before to diabetic retinopathy and other eye diseases. In this new work, they discovered that during ...
TipRanks on MSN2d
EyePoint Pharmaceuticals Completes Promising Study on EYP-1901 for Diabetic Retinopathy
This study is significant as it explores a potential new treatment option for diabetic retinopathy, a leading cause of blindness. The intervention tested was EYP-1901, a Tyrosine Kinase Inhibitor, ...
British number one blind golfer Billy McAllister recalls his journey in the sport after completely losing his eyesight in ...
Macular edema (ME), a leading cause of central vision loss, is often treated with anti-vascular endothelial growth factor ...
A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.
Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results